Kentucky Department for Medicaid Services & Magellan Medicaid Administration March 2011.

Slides:



Advertisements
Similar presentations
October 2009 Presentation by EDS Provider Relations Field Consultants UB-04 Billing Medicare Replacement Plans.
Advertisements

Pharmacy Services Agreements Dimitry Gotlinsky Western University Managed Care Clerkship ProPharma Pharmaceutical Consultants, Inc. 5/08/06.
Introduction to Medical Informatics Physician Office Workflows COMMON WORKFLOW CHALLENGES PHYSICIAN OFFICE.
Being More Appealing Bobbi Buell ION October, 2008.
©2011 Hewlett-Packard Development Company, L.P. The information contained herein is subject to change without notice Georgia Medicaid Fair Crossovers Presentation.
New York State Medicaid Fee-for-Service (FFS) Pharmacy Prior Authorization Programs Presented by: Magellan Medicaid Administration, Inc. & New York State.
1 Louisiana Medicaid National Drug Code (NDC) Transitional Requirements for Claims Submission On-Line Webinar February 3-6, 2009.
2 Agenda Goals of documentation training Iowa Administrative Code SURS Reviews Questions & answers.
1 February 2010 Pharmacy Benefits Consolidation Implemented on December 31, 2009.
New York State EPIC Program January 2012 Changes.
Proprietary & Confidential1 Training Seminar An Overview of Your Prescription Drug Benefit February 8, 2008 William F. Laman Public Library.
Copyright © 2008 Delmar Learning. All rights reserved. Chapter 4 Life Cycle of an Insurance Claim.
Therapeutic Formula Training Part 2 Working with Medi-Cal May 2013.
Third Party Liability & Act 62 COORDINATION OF BENEFITS DGS ANNEX COMPLEX 116 EAST AZALEA DRIVE PETRY BUILDING #17 HARRISBURG, PA
Pharmacy Program Initiatives Threshold, Mandatory Generic, Maximum Allowable Cost (MAC) Javier Menendez, RPh Pharmacy Manager Department of Medical Assistance.
1 District of Columbia Medical Assistance Administration Expedited Prior Authorization Pharmacy Guidance NOTE: As of October 1, 2008, the Medical Assistance.
© 2005 National Mental Health Association The Medicare Drug Benefit: What Is It and What Does it Mean for Mental Health? Get Educated, Get Enrolled An.
From Registration to Accounts Receivable – The Whole Can of Worms 2007 UBO/UBU Conference 1 Briefing:Unraveling the Mystery of Pharmacy Claims Date:21.
INTEGRATED CARE MANAGEMENT AND QUALITY IMPROVEMENT South Carolina KePRO QIO Request Submission Requirements New 6/14/2012.
Anthem Healthy Indiana Plan (HIP)
Food and Drug Administration Center for Biologics Evaluation and Research The Office of Cellular, Tissue and Gene Therapies Web Seminar Series presents:
LA Medicaid HEALTHCARE FINANCIAL MANAGEMENT ASSOCIATION PRESENTATION January 30, 2009.
1. 2 Provider Information Changes in Pharmacy Billing Procedures Website Information Call Center Prior Authorization Information Contact Information Questions.
Provider Revalidation & Application Fees. Agenda Objectives Revalidation of Enrollment Overview Application Fees How to Complete the Process Session Review.
Home and Community- Based Services Waiver Program HP Provider Relations/October 2015.
Virginia Medicaid Preferred Drug List and Other Pharmacy Programs: What You Need To Know Presented by: Department of Medical Assistance Services and First.
Health Insurance Designed for the Graduate Students employed by the THE TEXAS A&M UNIVERSITY SYSTEM Underwritten By: Companion Life Insurance.
HP Provider Relations October 2011 CMS-1500 Billing Medicare Replacement Plans.
Washington State Rx Services: Prescription Benefit Update Elizabeth James, PharmD October 16, 2007.
Health Insurance designed for the International Students of the THE TEXAS A&M UNIVERSITY SYSTEM Underwritten By: Companion Life Insurance Company.
© 2005 National Mental Health Association The Medicare Drug Benefit: What Is It and What Does it Mean for Mental Health?
URx : Rethinking our Rx program: A New Strategic Approach.
Virginia Medicaid Preferred Drug List Educational Outreach Efforts: Overview and Accomplishments Presented to: PDL Implementation Advisory Group March.
Overview of CISI Benefits & Procedures For the Participants of Rotary International 2012.
Prior Authorization Criteria for PDL Classes: Alzheimer’s Anti-emetics High Potency Statins Hormone Replacement Therapy Multiple Sclerosis – Tysabri Charles.
Kentucky Medicaid ❶ Helpful Links ❷ Billing Instruction Updates ❸ ICD-10 ❹ KYHealth Net ❺ Prior Authorizations ❻ Contacts ❼ Questions and Answers.
October 2009 Presented by EDS Provider Field Consultants Home Health Billing and Common Denials.
PRESENTED BY MSG ONLINE WEBINARS COPY WRITE 2010© Medical Billing Continuing Education Course.
October 2009 Presented by EDS Provider Field Consultants Hospice Program.
Beginning Billing Workshop Practitioner Colorado Medicaid 2015.
Member Mail Order Helpful Hints, Reminders and Tools.
PCS0049 (09/08) MDwise Care Select Overview Presented by MDwise October 6-8, 2008.
State of New Hampshire Pharmacy Benefit Changes Effective November 1, 2011 Presented By: Melisa Briggs.
HP Provider Relations October 2011 Medical Review Team.
Overview of CISI Benefits & Procedures For the Participants of Rotary International 2011.
1 Governor’s Office of Health Policy and Finance MaineCare Pharmacy Initiatives.
High Plains Educational Cooperative 10/1/2015 Open Enrollment August 5 th & 6 th, 2015.
Evaluation of Virginia’s Preferred Drug List: 2 nd Quarter Interim Report Policy and Research Division June 22, 2004Department of Medical Assistance Services.
Status Report on Development of a Medicaid Preferred Drug List Program Presentation to: The Medicaid Pharmacy & Therapeutics Committee Cynthia B. Jones.
Service Authorization for Alzheimer's Assisted Living Waiver (Service Type 0980) Presented by: KEPRO INTEGRATED CARE MANAGEMENT AND QUALITY IMPROVEMENT.
Medicaid Fee-for-Service: Prior Authorization Criteria & the Role of the DUR Board Charles Agte, Pharmacy Administrator Health Care Services June 19, 2013.
RESEARCH AND RESOLVE Professional Claim Denials HP Provider Relations/June 2014.
High Plains Educational Cooperative 10/1/2015 Open Enrollment August 5 th & 6 th, 2015.
HP Provider Relations October 2010 Web interChange Basic Functions.
Medical Coding & Insurance Unit 8 Seminar. CMS Centers for Medicare and Medicaid Services (CMS) Centers for Medicare and Medicaid Services (CMS) Purpose:
HP Provider Relations October 2010 CMS-1500 Billing Medicare Replacement Plans.
Medicaid QIO Training Sessions Medicaid QIO Training Sessions November 7 th and 8 th, 2012 November 7 th and 8 th, 2012 Medicaid QIO Training Sessions.
Drug Formulary Development & Management
Technology, Information Systems and Reporting in Pharmacy Benefit Management Presentation Developed for the Academy of Managed Care Pharmacy Updated: February.
© 2007 NSCLC 1 LAAC Armchair Training Medicare Part D: Accessing Drugs Coverage Determinations, Exceptions, Appeals and Grievances March 8, 2007 Georgia.
Pharmacy Benefit Management (PBM) 101
Medicare Part D Prescription Drug Benefit Highlights Presentation Developed for the Academy of Managed Care Pharmacy Updated: February 2015.
Kentucky Medicaid and EPSDT Stephanie Bates Branch Manager Disease and Case Management Kentucky Department for Medicaid Services.
MEDICAL BILLING FOR DENTISTS
Greater Chicago Epilepsy Consumer Conference 2016
Tab Runs/Cost Audit Reports
Primum non nocere Olabisi Oshikanlu M.D., F.A.A.P
Drug Formulary Development & Management
Presentation transcript:

Kentucky Department for Medicaid Services & Magellan Medicaid Administration March 2011

Website Overview

 Providers Tab  Billing o Billing manuals o Payer specs  Communications Registration o Distribution List o Fax Blast  Drug Information o Preferred Drug List (PDL) o Over-The-Counter (OTC) Drug List o Maximum Quantity Limits List o ICD-9 Drug List  Epocrates o Drug formulary  Fraud and Abuse  Maximum Allowable Cost (MAC)  Notices  Prior Authorization (PA) o PA forms  Quarterly Newsletter  Remittance Advice  Seminars Magellan Medicaid Administration | 3  NCPDP D. 0 Tab  Provider Notices  Education o FAQs  NCPCP Resources  CMS Resources  Additional Resources  PIDL Tab  Drug List o Physician Injectable Drug List (PIDL)  Billing Instructions  Education o PIDL Tutorial o PIDL FAQs  Provider Notices  Additional Resources  Contacts  Home Page  Link to Current PDL o The PDL is also located on the Providers tab under Drug Information  Link to Contact Information o Website information o Pharmacy Support o Clinical Support o Provider Services o Member Services  Site Map  Web Announcements o Meeting announcements and cancellation notices o Upcoming changes o Emergency announcements

 Committees Tab  Pharmacy and Therapeutics Advisory Committee (PTAC) o Meeting dates o Agenda, Drug Review Options, and Secretary’s Final Decisions o Speaker Request Form o Member list  Drug Management Review Advisory (DMRAB) o Meeting dates o Agenda, minutes, and presentation o Speaker Request From o Member list  Diabetic Supplies Tab  Preferred Product List  FAQs  Related Provider Notices  Contact Information Magellan Medicaid Administration | 4  Tobacco Cessation Tab  Drug Information  Referral Form o This must be completed by the member and the prescribing physician  Contact Information  Provider Notices  Members Tab  Member Handbook  Co-pay Information  Drug Information o Preferred Drug List (PDL) o Over-The-Counter (OTC) Drug List o Maximum Quantity Limits List  Provider Directory  Medicare Information

Magellan Medicaid Administration | 5

Magellan Medicaid Administration | 6

 Pharmacy Support Center – (800)  Providers only  Claim rejections/denials  Overrides o Lock-In o Early Refills o Timely Filing o Claims over $  Clinical Support Center – (800)  Providers only  Request prior authorization  Questions on a prior authorization request  Diabetic Supplies  Prior Authorization (800)  Claims Inquiry (800) o Claims processed prior to October 5, 2010 will need to be directed to HP (formerly EDS) at (800)  Missing Claims Payment / Remittance Advices (835s)  Provider Operations at (804) or Magellan Medicaid Administration | 7

Magellan Medicaid Administration | 8

Magellan Medicaid Administration | 9

Magellan Medicaid Administration | 10

Magellan Medicaid Administration | 11

Magellan Medicaid Administration | 12

Magellan Medicaid Administration | 13

Magellan Medicaid Administration | 14

Magellan Medicaid Administration | 15

Magellan Medicaid Administration | 16

Magellan Medicaid Administration | 17

Magellan Medicaid Administration | 18  1st Tier Medications ($) – Typically preferred generic medications. A generic medication is identified by its chemical name, while a manufacturer assigns a brand name. Also, the price of the generic medication is usually lower than that of a brand name medication. Both generic and brand name medications may require PA.  2nd Tier Medications ($$) – Typically preferred brand medications. Preferred brand medications may have generic equivalents. Once a branded medication is available as a generic alternative, the branded medication may move to non-preferred status and the generic medication may become the preferred medication. Some Tier 2 medications may require PA.  3rd Tier Medications ($$$) – Typically, branded medications which are not 1st or 2nd Tier. Non-preferred medications are usually available at the highest co-pay tier for members. Prior authorization is required for all non-preferred medications.

 Clinical Criteria (CC) – Due to the nature of some medications, prior authorization may be required for the medication to be covered at any co-pay tier. Medications that require prior authorization will require that certain clinical criteria be met. Medications may require the use of preferred medications (subject to PDL), in addition to satisfying appropriate clinical criteria, before approval (prior authorization) can be considered. If a medication requires PA, the ordering physician should contact Magellan Medicaid Administration, the plan’s pharmacy benefit administrator. Also, prescriptions exceeding such plan limitations as Quantity Limits (QL), Step Therapy (ST), Maximum Duration (MD), Age Edit (AE), in addition to those subject to Clinical Criteria (CC), will also require PA.  Step Therapy (ST) – Step therapy is an electronic PA process that takes place at t he time the pharmacy submits the claim. For example, in the case of medications considered “second-line” agents, the system will look at the member’s paid claims history, and if a claim(s) for the required “first-line” medication(s) is located, the system will approve the claim. If “first-line” medication(s) are not located, the system will not approve the claim, and will return a message to the pharmacy advising that the Step Therapy protocol has not been satisfied and prior authorization is required. At that time, the pharmacy may contact the physician and request that they contact Magellan Medicaid Administration for PA Magellan Medicaid Administration | 19

 Quantity Limits (QL) – Quantity limits have been placed on medications to be consistent with the maximum dosage that the Food and Drug Administration (FDA) has approved to be both safe and effective. Medications where the quantity exceeds the FDA’s maximum daily dose will require PA. Prescriptions exceeding plan limitations will require PA.  Medication with Maximum Duration (MD) – Medications indicated will be available for a defined period of days per rolling year (365 days) before requiring a new or additional PA.  Age Edit (AE) – Medications indicated are available for members above or below XX age without PA. Magellan Medicaid Administration | 20

 Maintenance Drugs – Maintenance medications in the following classes can be processed for up to a 92 day supply and 100 units:  Antianginals  Antiarrhythmics  Antiarthritics  Antidiabetics  Antihypertensives  Cardiac Glycosides  Digestants  Diuretics  Oral Contraceptives  Progesterones  Thyroid Preparations Magellan Medicaid Administration | 21

Magellan Medicaid Administration | 22  Androgen Hormone Inhibitors  Anticonvulsants: Second Generation  Antihyperkinesis Agents  Antidepressants: SNRIs  Atypical Antipsychotics  Diabetes: DPP-4 Inhibitors  Growth Hormones  Hematological Agents  Hematology; Bleeding Disorders  Laxatives and Cathartics  Multiple Sclerosis Agents  Non-Ergot Dopamine Receptor Agonists  Ophthalmic Antibiotics, Macrolides  Ophthalmic Antibiotics, Quinolone  Pulmonary Hypertension  Sedative Hypnotics  Sympatholytics  Topical Anesthetics

Magellan Medicaid Administration | 23

Magellan Medicaid Administrati on | 24

 Examples of provider fraud/abuse include:  Billing for services or equipment that the patient did not receive  Charging recipients for services over and above reimbursement  Double billing or other illegal billing practices  Submitting false medical diplomas or licenses in order to qualify as a Medicaid provider  Ordering tests, prescriptions or procedures the patient does not need  Rebating or accepting a fee or a portion of a fee for a Medicaid patient referral  Failing to repay or make arrangements for the repayment of identified overpayments  Examples of recipient fraud/abuse include:  Forging or altering prescriptions  Allowing others to use a Medicaid card to get services  Failure to keep the Medicaid card safe  Intentionally seeking and receiving excessive drugs, services or supplies  Collusion with providers in order to get services or supplies  Providing false information in order to qualify for Medicaid  Drug diversion Magellan Medicaid Administration | 25

Magellan Medicaid Administration | 26

Magellan Medicaid Administration | 27

Magellan Medicaid Administration | 28

Magellan Medicaid Administration | 29

Magellan Medicaid Administration | 30

Magellan Medicaid Administration | 31

Magellan Medicaid Administration | 32

Magellan Medicaid Administration | 33

 Only a patient or family member can appeal a prior authorization denial  The member has 30 days from receipt of the denial letter to submit a written appeal Kentucky Department for Medicaid Services Division of Administration and Financial Management Administrative Services Branch, 6W-C 275 East Main Street Frankfort, KY  The prescribing physician can attend the appeal hearing and testify on the patient’s behalf Magellan Medicaid Administration | 34

Magellan Medicaid Administration | 35

Magellan Medicaid Administration | 36

Magellan Medicaid Administration | 37

Magellan Medicaid Administration | 38

Magellan Medicaid Administration | 39

Magellan Medicaid Administration | 40

Magellan Medicaid Administration | 41

Magellan Medicaid Administration | 42

Magellan Medicaid Administration | 43

Magellan Medicaid Administration | 44

Magellan Medicaid Administration | 45

Magellan Medicaid Administration | 46

 Kentucky Medicaid has a policy in place for the replacement of medication for members  Medications can be replaced when they are lost, stolen, destroyed, or kept by a facility  A one time override is given if back-up documentation is not provided  Fire marshal, police, or insurance report  Nursing facility statement on letterhead  Statement from Red Cross or other organization  Members or providers can contact Member Services at (800) to initiate the replacement Magellan Medicaid Administration | 47

Questions? Kasie Purvis, Provider Relations Manager (314)